The Coleção de Flebotomíneos  held at Fiocruz Minas is a curated biological collection comprising approximately 80 000 individual specimens of 370 species of sand flies . These were mostly collected from the Americas in the last 80 years by entomologists interested in understanding and controlling the vector-borne disease leishmaniases. Since 2010, the metadata of each biological specimen held in FIOCRUZ/COLFLEB, including the back catalogue of those deposited in previous decades, has been digitized. Here, we present the resulting electronic catalog containing records for 72,624 of the specimens, including all of the available provenance information associated with each specimen. The catalog is published online through the speciesLink network and the Sistema de Informação sobre a Biodiversidade Brasileira (SiBBr). A Coleção de Flebotomíneos  da Fiocruz Minas é uma coleção biológica composta por aproximadamente 80.000 exemplares representando 370 espécies de flebotomíneos . Estes insetos foram coletados principalmente nas Américas nos últimos 80 anos por entomologistas interessados em entender e contribuir com conhecimento para o controle das leishmanioses, doenças causadas por protozoários transmitidos por vetores. Desde 2010, os metadados de cada espécime mantido na FIOCRUZ/COLFLEB, incluindo os dados retroativos daqueles depositados em décadas anteriores, estão sendo digitalizados. Aqui, apresentamos o catálogo eletrônico resultante contendo registros para 72.624 exemplares, incluindo todas as informações associadas disponíveis para cada espécime. O catálogo é publicado online por meio da rede speciesLink e do Sistema de Informação sobre a Biodiversidade Brasileira (SiBBr). These collections are especially important for insects of medical and veterinary importance, where accurate taxonomic identification is necessary for understanding and intervening in the epidemiology of vector-borne diseases . The “Coleção de Flebotomíneos” (“Phlebotomine Collection”) is held at the Instituto René Rachou, Fiocruz Minas (FIOCRUZ/COLFLEB), a federal public health research institution in Belo Horizonte, Minas Gerais, Brazil. FIOCRUZ/COLFLEB is a biological collection of preserved sand flies . These small insects are of considerable medical and public health importance because their blood-feeding adult females transmit protozoan parasites of the genus Leishmania, the etiological agent of leishmaniases, in addition to other bacterial and viral pathogens, which infect both human and non-human vertebrates . The insect specimens deposited in FIOCRUZ/COLFLEB come from many different research projects carried out over the last 80 years. These projects were undertaken in many different areas of leishmaniases transmission, as well as from wild environments where leishmaniasis has never been recorded. The deposited sand flies were usually collected using light traps and have been identified by highly trained specialists using available taxonomic keys , 4. The specimens can support research in the areas of taxonomy and systematics –7, and their associated data can be used in ecological niche/species distribution modelling , among other applications .Biological collections are repositories of biodiversity housing specimens and their related information, which can be used in various areas of scientific research . Our data are available in the Sistema de Informação sobre a Biodiversidade Brasileira (SiBBr), an online platform that integrates data and information about biodiversity and ecosystems. SiBBr is the Brazilian node of the Global Biodiversity Information Facility (GBIF) , an internationally recognized resource for collating biological occurrence data. Our dataset has been submitted to GBIF, and is publicly available for use by others there  taxonomy ; (ii) collection details, including the collectors (recordedBy), collection date, trapping method, trap identification number, collection site description ; (iii) geolocation data ; and (iv) catalogue reference data . The associated data for each physical object in our collection has a paper card with many fields referring to specimen provider, location, quantity of specimens, and so on. Data from these cards have been digitized by a dedicated member of the collection staff since 2010. The data are provided in the Darwin Core format .Phlebotomine sand flies are insects of medical importance because they are involved in the transmission of pathogens between human and non-human animals. Approximately 1,000 sand flies species have been described, of which 530 are known to occur in the neotropical and nearctic regions . The number of specimens in the collection increased considerably during the 1960s and 1970s. In the last 20 years, fossil specimens, as well as voucher specimens from DNA-based barcoding studies and other epidemiological studies involving fieldwork, have continued to be deposited in the collection , 15.FIOCRUZ/COLFLEB was officially started in 1953 as part of the work of Professor Amilcar Vianna Martins and Alda Lima Falcão, in collaboration with the technician João Evangelista da Silva FIOCRUZ/COLFLEB contains 922 type specimens belonging to 151 species, including holotypes, allotypes, paratypes, plesiotypes, cotypes, topotypes, homeotypes, syntypes and neotypes. FIOCRUZ/COLFLEB also has a diverse collection of fossil species of neotropical sand flies, currently comprising 47 ambers from the Dominican Republic, within which 162 sand flies of nine species are preserved. Additionally, FIOCRUZ/COLFLEB has over 700 voucher specimens deposited from continuing DNA barcoding studies., FIOCRUZ/COLFLEB has the most published online data. Our online catalog is also integrated into the speciesLink network  and the Sistema de Informação sobre a Biodiversidade Brasileira (SiBBr) .Efforts to digitize the metadata of biological specimens held in FIOCRUZ/COFLEB have been ongoing since 2010. Among the biological collections of the various regional institutions that comprise Fiocruz 2-baited CDC-like light traps; and Shannon traps. Collections were made in different environments, including domestic and peridomestic  and relatively undisturbed sylvatic and wild area . Our specimens come from all 27 states of Brazil, and 19 other different countries of the Americas.The sand flies held in FIOCRUZ/COLFLEB are adults and were collected using various methods, including resting collection from artificial and natural surfaces using either mechanical or manual aspirators (“pooters”); human-landing capture unbaited and COThe live-caught insects are permanently mounted on glass microscope slides and preserved in either Berlese medium or Canada Balsam, while the fossil specimens are kept in plastic vials. All types are labelled with color-coded labels. and Young and Duncan .Insects were identified by experienced taxonomists using keys available in the literature: those of Galati , with 57 possible terms available. All mandatory fields are present and have undergone screening in the FIOCRUZ IPT (Integrated Publishing Toolkit) , which is the GBIF software to provide data through their network. Metadata fields are also available on the online pages.The dataset is in Darwin Core format –7, and ecological niche modelling , among others , to vector control activities , 20.The data associated with the biological specimens deposited in FIOCRUZ/COLFLEB are of importance because they (i) describe the distribution of sand flies in different parts of Brazil, and (ii) have a good temporal coverage – some specimens date back to 1939, while the most recent deposit was recorded in 2021. These data can be used for many different applications, in different research areas, including taxonomy and systematics  . Essas coleções são especialmente importantes para insetos de importância médica e veterinária, cuja identificação taxonômica precisa é necessária para entender e elaborar intervenções na epidemiologia de doenças de transmissão vetorial . A “Coleção de Flebotomíneos” está localizada no Instituto René Rachou, Fiocruz Minas (FIOCRUZ/COLFLEB), instituição federal de pesquisa em saúde pública em Belo Horizonte, Minas Gerais, Brasil. FIOCRUZ/COLFLEB é uma coleção biológica de flebotomíneos  preservados em lâminas de microscopia. Esses pequenos insetos são de considerável importância médica e de saúde pública, pois as fêmeas adultas são hematófagas e transmitem parasitas protozoários do gênero Leishmania, agente etiológico das leishmanioses, além de outros patógenos bacterianos e virais, que infectam vertebrados humanos e não humanos . Os espécimes de insetos depositados na FIOCRUZ/COLFLEB são provenientes de diversos projetos de pesquisa realizados ao longo dos últimos 80 anos. Esses projetos foram realizados em muitas áreas diferentes de transmissão de leishmaniose, bem como em ambientes silvestres onde a leishmaniose nunca foi registrada. Os flebotomíneos depositados geralmente foram coletados usando armadilhas de luz e foram identificados por especialistas altamente treinados usando chaves taxonômicas disponíveis , 4. Os espécimes podem subsidiar pesquisas nas áreas de taxonomia e sistemática –7, e seus dados associados podem ser usados em modelagem de distribuição de nichos ecológicos/espécies , entre outras aplicações .As coleções biológicas são repositórios de espécimes que abrigam a biodiversidade e suas informações relacionadas, que podem ser utilizados em diversas áreas de pesquisa científica . Nossos dados estão disponíveis no Sistema de Informação sobre a Biodiversidade Brasileira (SiBBr), plataforma online que integra dados e informações sobre biodiversidade e ecossistemas. O SiBBr é o nó brasileiro do Global Biodiversity Information Facility (GBIF) , uma infraestrutura reconhecida internacionalmente para a disponibilização de dados da biodiversidade. Nosso conjunto de dados foi submetido ao GBIF e está disponível publicamente para uso por outros  taxonomia ; (ii) informações de campo, incluindo os coletores (recordedBy), data de coleta, método de coleta, identificação da armadilha, descrição do sítio de coleta ; (iii) dados geográficos ; e (iv) referências aos dados de tombamento e catalogação . Os dados associados a cada objeto físico de nossa coleção possuem um cartão de papel com diversos campos referentes ao depositante do espécime, localização, quantidade de espécimes etc. Os dados desses cartões foram digitalizados por um membro dedicado da equipe de coleta desde 2010. Os dados são fornecidos no formato Darwin Core .Os flebotomíneos são insetos de importância médica, pois estão envolvidos na transmissão de patógenos entre animais humanos e não humanos. Aproximadamente 1.000 espécies de flebotomíneos foram descritas, das quais 530 são conhecidas por ocorrerem nas regiões neotropicais e neárticas . O número de espécimes na coleção aumentou consideravelmente durante as décadas de 1960 e 1970. Nos últimos 20 anos, espécimes fósseis, bem como espécimes de comprovantes de estudos de código de barras baseados em DNA e outros estudos epidemiológicos envolvendo trabalho de campo, continuaram a ser depositados na coleção , 15.A FIOCRUZ/COLFLEB foi iniciada oficialmente em 1953 como parte do trabalho dos pesquisadores Amilcar Vianna Martins e Alda Lima Falcão, em colaboração com o técnico João Evangelista da Silva barcoding).A FIOCRUZ/COLFLEB contém 922 espécimes-tipo pertencentes a 151 espécies, incluindo holótipos, alótipos, parátipos, plesiótipos, cotipos, topótipos, homeótipos, síntipos e neótipos. A FIOCRUZ/COLFLEB também possui uma coleção diversificada de espécies fósseis de flebotomíneos neotropicais, atualmente composta por 47 âmbares da República Dominicana, dentro dos quais estão preservados 162 flebotomíneos de nove espécies. Além disso, a FIOCRUZ/COLFLEB possui mais de 700 espécimes-testemunhos depositados a partir de estudos de código de barras de DNA  .Esforços para digitalizar os metadados dos espécimes biológicos mantidos na FIOCRUZ/COFLEB estão em andamento desde 2010. Dentre as coleções biológicas das diversas instituições regionais que compõem a Fiocruz 2; e armadilhas Shannon. As coletas foram feitas em diferentes ambientes, incluindo doméstico e peridoméstico  e áreas silvestres e selvagens relativamente intocadas . Nossos exemplares são provenientes de todos os 27 estados do Brasil e de outros 19 países diferentes das Américas.Os flebotomíneos depositados na FIOCRUZ/COLFLEB são adultos e foram coletados por diversos métodos, incluindo coleta em repouso de superfícies artificiais e naturais com aspiradores mecânicos ou manuais (“pooters”); armadilhas de luz tipo CDC sem isca e com isca de COOs insetos capturados vivos são permanentemente montados em lâminas de microscópio de vidro e preservados em meio Berlese ou Bálsamo do Canadá, enquanto os espécimes fósseis são mantidos em frascos de plástico. Todos os tipos são rotulados com etiquetas codificadas por cores. e Young e Duncan .Os insetos foram identificados por taxonomistas experientes usando chaves disponíveis na literatura: as de Galati , com 57 termos disponíveis. Todos os campos obrigatórios estão presentes e passaram por triagem no IPT da FIOCRUZ (Integrated Publishing Toolkit) , que é o software do GBIF para fornecer dados através de sua rede. Os campos de metadados também estão disponíveis nas páginas online.O conjunto de dados está no formato Darwin Core –7, e modelagem de nicho ecológico , entre outros , para subsidiar atividades de controle , 20.Os dados associados aos espécimes biológicos depositados na FIOCRUZ/COLFLEB são importantes porque (i) descrevem a distribuição dos flebotomíneos em diferentes partes do Brasil, e (ii) têm uma boa cobertura temporal – alguns espécimes datam de 1939, enquanto o depósito mais recente foi registrado em 2021. Esses dados podem ser usados para muitas aplicações diferentes, em diferentes áreas de pesquisa, incluindo taxonomia e sistemática  Reviewer name and names of any other individual's who aided in reviewer Leonard E. MunstermannDo you understand and agree to our policy of having open and named reviews, and having your review included with the published papers. YesIs the language of sufficient quality?NoPlease add additional comments on language quality to clarify if needed
Whereas the information content is clear, it is often presented as lengthy phrases joined by conjunctions. In Engllish, These clauses or phrases will be sepaarated by a period (full stop). Occasional unnecessary wordiness was also encountered.Are all data available and do they match the descriptions in the paper? YesAdditional CommentsThis is a very important database for research in phlebotomine taxonomy, as well as for understanding the epidemiology of leishmaniasis in the Americas. The Fiocruz Minas laboratories are renown for its current and historical collections, its highly skilled phlebotomine taxonomists, and its welcoming atmosphere. Are the data and metadata consistent with relevant minimum information or reporting standards? See GigaDB checklists for examples http://gigadb.org/site/guideYesAdditional CommentsIs the data acquisition clear, complete and methodologically sound?YesAdditional CommentsIs there sufficient detail in the methods and data-processing steps to allow reproduction?YesAdditional CommentsIs there sufficient data validation and statistical analyses of data quality? Not my area of expertiseAdditional CommentsIs the validation suitable for this type of data?YesAdditional CommentsAgain, I am unsure about "validation". Certainly the species indentifications (the most important data) are of the highest caliber.Is there sufficient information for others to reuse this dataset or integrate it with other data?YesAdditional CommentsAny Additional Overall Comments to the AuthorPlease break up your lengthy sentences with several clauses  –held at the Instituto René Rachou, Fiocruz Minas (FIOCRUZ/COLFLEB), a federal public health research institution in the city of Belo Horizonte, in the state of Minas Gerais in Brazil is a biological collection of sand flies  small insects of considerable medical and public health importance because their blood-feeding adult females transmit protozoan parasites of the genus Leishmania, the etiological agent of leishmaniases, in addition to other bacterial and viral pathogens, which infect both human and non-human vertebrates [3] ]
.A SUGGESTED REWRITE: The Collection of Phlebotomines (or “Coleção de Flebotomíneos” in Portuguese) is held at a federal public health institution—the Instituto René Rachou, Fiocruz Minas (FIOCRUZ/COLFLEB) located in the city of Belo Horizonte, Minas Gerais, Brazil. It consists of a preserved collection of small flies, the phlebotomine sand flies . They are of considerable medical and public health importance, because by means of the blood feeding habit of the adult females, these flies can transmit a variety of protozoan, bacterial and viral diseases. The most important of these Is human leishmaniasis, a protozoan of the genus Leishmania [3]. RecommendationMinor Revision Reviewer name and names of any other individual's who aided in reviewer no bodyDo you understand and agree to our policy of having open and named reviews, and having your review included with the published papers. YesIs the language of sufficient quality?NoPlease add additional comments on language quality to clarify if needed
Auhors should improve itAre all data available and do they match the descriptions in the paper? YesAdditional CommentsAre the data and metadata consistent with relevant minimum information or reporting standards? See GigaDB checklists for examples http://gigadb.org/site/guideYesAdditional CommentsIs the data acquisition clear, complete and methodologically sound?YesAdditional CommentsIs there sufficient detail in the methods and data-processing steps to allow reproduction?YesAdditional CommentsIs there sufficient data validation and statistical analyses of data quality? Not my area of expertiseAdditional CommentsIs the validation suitable for this type of data?YesAdditional CommentsIs there sufficient information for others to reuse this dataset or integrate it with other data?YesAdditional CommentsAny Additional Overall Comments to the AuthorRecommendationAccept Reviewer name and names of any other individual's who aided in reviewer EDUARDO A. REBOLLAR-TELLEZDo you understand and agree to our policy of having open and named reviews, and having your review included with the published papers. YesIs the language of sufficient quality?YesPlease add additional comments on language quality to clarify if needed
The manuscript is short, but well-written.Are all data available and do they match the descriptions in the paper? YesAdditional CommentsThe manuscript and the database if published represent an invaluable referencie source to all those researchers working on leishmaniasis vectors.Are the data and metadata consistent with relevant minimum information or reporting standards? See GigaDB checklists for examples http://gigadb.org/site/guideYesAdditional CommentsAccess to Fiocruz/COLFLEB - Coleção de Flebotomíneos had no problem when using the provided link.Is the data acquisition clear, complete and methodologically sound?YesAdditional CommentsYes, the manuscript explains sufficiently well how database was originated.Is there sufficient detail in the methods and data-processing steps to allow reproduction?YesAdditional CommentsTha manuscript is not an experimental design, so perhaps the comments do not apply to the above-question.Is there sufficient data validation and statistical analyses of data quality? YesAdditional CommentsNo additional commentsIs the validation suitable for this type of data?YesAdditional CommentsNo additional commentsIs there sufficient information for others to reuse this dataset or integrate it with other data?YesAdditional CommentsYes, the manuscript is clear on this issue of how the dataset was elaborated and its potential use in different research fields. Any Additional Overall Comments to the AuthorPublication of this manuscript will certainly be a valuable resource to other researchers and institutions and also, will allow the recognition of the importance of preserving insect collection and its associated datasets.RecommendationAccept Upload additional filesDRR-202202-06/form/DRR-202202-06_Data-Review-MAT.pdfReviewer name and names of any other individual's who aided in reviewer Mary Ann TuliDo you understand and agree to our policy of having open and named reviews, and having your review included with the published papers. YesIs the language of sufficient quality?YesPlease add additional comments on language quality to clarify if needed
Are all data available and do they match the descriptions in the paper? NoAdditional CommentsNot all specimens are classified to species level, but the paper does not state they are so I think this is OK. They are all sand flies.
Many of the 'locality' values in the GBIF download contain non-ascii characters which makes the value unreadable.
Many of the specimens do not include GPS values. I initially thought that it was just the older records  but this does not seem to be the case, thus probably reflects how data for those records were collected.Are the data and metadata consistent with relevant minimum information or reporting standards? See GigaDB checklists for examples http://gigadb.org/site/guideYesAdditional CommentsIs the data acquisition clear, complete and methodologically sound?YesAdditional CommentsIs there sufficient detail in the methods and data-processing steps to allow reproduction?YesAdditional CommentsIs there sufficient data validation and statistical analyses of data quality? YesAdditional CommentsIs the validation suitable for this type of data?YesAdditional CommentsIs there sufficient information for others to reuse this dataset or integrate it with other data?YesAdditional CommentsAny Additional Overall Comments to the AuthorRecommendationAccept Comments to the AuthorThanks for returning this so quickly.


O Lúpus Eritematoso Sistêmico (LES) é uma doença autoimune com um grande espectro de manifestações clínicas. Dentre os órgãos afetados, o sistema cardiovascular tem importância clínica relevante por estar associado a maior mortalidade nestes pacientes. O coração pode ser afetado em quaisquer de suas estruturas, sendo a miocardite lúpica um grande desafio diagnóstico na prática clínica.Exames não invasivos como eletrocardiograma e ecocardiograma não são sensíveis ou específicos o suficiente para esse diagnóstico. A ressonância magnética cardíaca (RMC) é a modalidade de imagem preferida para diagnóstico de miocardite, porém tem suas contraindicações, tais como portadores de implantes metálicos ou o uso de gadolínio na doença renal crônica. Desta forma, tem-se estudado alternativas diagnósticas com maior sensibilidade, especificidade e com menor risco para o paciente.A biópsia miocárdica, apesar de ser considerada o padrão-ouro, tem a grande desvantagem de ser um procedimento invasivo com riscos inerentes ao procedimento.18F-FDG PET/CT) surge como um novo método de imagem para avaliação de processos inflamatórios em doenças reumatológicas, incluindo o LES. O 18F-FDG PET/CT combina a técnica da medicina nuclear com imagens de tomografia computadorizada.O uso da tomografia por emissão de pósitrons associado a tomografia computadorizada com fluorodeoxiglicose  is an autoimmune disease with a wide spectrum of clinical manifestations. The cardiovascular system has relevant clinical importance among the affected organs because it is associated with higher mortality in these patients. The heart can be affected in any structure, and lupus myocarditis is a major diagnostic challenge in clinical practice.Non-invasive tests such as electrocardiograms and echocardiograms are not sensitive or specific enough for this diagnosis. Cardiac magnetic resonance imaging (CMR) is the preferred imaging modality for diagnosing myocarditis, but it has contraindications, such as patients with metallic implants or using gadolinium in chronic kidney disease.Thus, diagnostic alternatives with greater sensitivity, specificity, and less risk to the patient have been studied. The use of positron emission tomography associated with computed tomography with fluorodeoxyglucose (18F-FDG PET/CT) emerges as a new imaging method for evaluating inflammatory processes in rheumatologic diseases, including SLE.18F-FDG PET/CT combines the technique of nuclear medicine with computed tomography imaging.Despite being considered the gold standard, myocardial biopsy has the great disadvantage of being an invasive procedure with inherent risks.18F-FDG suppresses physiological glucose uptake by cardiomyocytes. Thus, if we visualize cardiac uptake of18F-FDG, uptake by inflammatory cells is inferred since they do not suffer interference in glucose uptake with this preparation.Few studies associate18F-FDG PET/CT with the diagnosis and follow-up of lupus myocarditis.The image of this case is of a female patient, 16 years old, hospitalized with persistent fever, significant weight loss, cough, edema, and menstrual delay. She initiated research for several infectious diseases, including tuberculous pericarditis and autoimmune diseases. Among the tests performed, the transthoracic echocardiogram showed a biventricular deficit, pulmonary arterial hypertension, and severe mitral regurgitation. It was decided to perform 18F-FDG PET/CT during the diagnostic investigation due to renal dysfunction. After performing this examination, which showed a marked and diffuse cardiac hyperuptake of FDG (18F-FDG PET/CT may be useful and promising in the diagnosis and follow-up of patients with lupus myocarditis.Although the myocardium can capture glucose as an energy substrate, in the investigation of cardiac inflammatory processes, the preparation with fasting of at least 12 hours, a low-carbohydrate diet, fat and use of heparin 15 minutes before injection of of FDG , the po of FDG . Consid


Assim, é possível caracterizar os diferentes fenótipos da hipertensão arterial,6 importante na determinação do prognóstico e da terapia individualizada.7De acordo com recomendações recentes,7 A MRPA associa-se a menor inércia terapêutica e ao maior engajamento e adesão do paciente ao tratamento, especialmente quando combinada com educação e aconselhamento,6 contribuindo para maior proteção CV.8A Monitorização Residencial da PA (MRPA) é o registro realizado pelo paciente ou outra pessoa treinada utilizando um aparelho automático, por vários dias, durante a vigília, no seu domicílio, com protocolo determinado. Tem boa aceitação pelo paciente, custo baixo, boa reprodutibilidade e valor prognóstico.O presente artigo teve como objetivo comparar as taxas de controle da PA pela medida no consultório e pela MRPA em duas populações de hipertensos em tratamento. Os indivíduos foram avaliados em 2019 e em 2020, após a introdução da MRPA de forma mais regular e frequente na prática de 274 consultórios médicos de cinco regiões brasileiras.Trata-se de um estudo multicêntrico, de dois cortes transversais, parte do registro nacional do controle da hipertensão arterial avaliado pela medida da PAC e MRPA (Registro LHAR).5 Os exames foram analisados por meio da plataforma TeleMRPA (www.telemrpa.com), ferramenta de laudo à distância por telemonitoramento.A PAC considerada foi a média de duas medidas realizadas com aparelho oscilométrico validado da marca OMRON modelo HEM-7320 no primeiro dia do protocolo de MRPA. O mesmo equipamento foi utilizado para a MRPA. Os pacientes ou seus acompanhantes foram instruídos a realizar seis medidas diárias de PA.1 Embora esses valores sejam menores que os adotados pelos europeus,6 mostraram maior correlação com PAC de 140/90mmHg e associaram-se a menor risco de lesão de órgão-alvo, de desfecho CV e mortalidade.9 As taxas de controle foram analisadas por sexo, grupo etário (≥ 60 anos e < 60 anos) e classificação do Índice de Massa Corporal (IMC).Dois pontos de corte foram considerados para determinar o controle da PAC: < 140/90mmHg e < 130/80mmHg. Para a MRPA, o ponto de corte foi < 130/80mmHg.6 Seguem os fenótipos: 1) hipertensão controlada (HC): PAC e MRPA normais; 2) hipertensão do avental branco não controlada (HABNC): PAC anormal e MRPA normal; 3) hipertensão mascarada não controlada (HMNC): PAC normal e MRPA anormal; e 4) hipertensão não controlada (HNC): PAC e MRPA anormais.A frequência dos fenótipos da HA foi determinada nos anos de 2019 e 2020, considerando-se PAC normal <140 e 90mmHg e MRPA normal <130 e 80mmHg Todos os participantes leram e assinaram o termo de consentimento livre e esclarecido. O estudo foi aprovado pelo Comitê de Ética em Pesquisa da Universidade Federal de Goiás (CAAE 08208619.8.0000.5078). Os dados foram analisados pelo do programa SPSS 27.0 (SPSS Inc.), considerando 5% como nível de rejeição da hipótese de nulidade para o Teste “t” de Student e Teste do Qui-quadrado.11 e provavelmente refletem um maior cuidado da mulher com sua saúde.12 A amostra de 2020 tinha média de idade significativamente maior que o grupo de 2019. As médias de pressão arterial sistólica (PAS) e pressão arterial diastólica (PAD) foram menores na MRPA que no consultório, -6,6/-4,5mmHg, respectivamente, em acordo com outras publicações.10 Foram observadas médias da PAD no consultório e na MRPA menores em 2020 comparadas a 2019, porém a diferença observada entre os dois grupos foi menor que 1mmHg , o que é frequentemente observado em estudos clínicos no Brasil,ue 1mmHg . Em 47,73 contudo já observadas em outros estudos brasileiros quando hipertensos são tratados por médicos especialistas, em especial cardiologistas.11As taxas de controle da PA na amostra total foram 57,7% pela PAC < 140/90mmHg, 28,8% pela PAC < 130/80mmHg e 45,1% pela MRPA < 130/80mmHg. . As taxa13 demonstrou maior proteção CV com o alcance de metas mais rigorosas da PA, o que tem sido considerado pelas diretrizes.Em comparação a 2019, em 2020, houve aumento das taxas de controle para PAC < 130/80mmHg  e MRPA < 130/80mmHg  . O estud14Importante ressaltar que a pandemia por COVID-19 ocorreu a partir de 2020 e poderia ter impactado negativamente as taxas de controle da PA; entretanto, houve aumento das taxas de controle. Estudo brasileiro recente com mais de 50 000 indivíduos avaliados não encontrou influência da pandemia sobre as taxas de controle pela PAC ou pela MRPA.12 mostraram aumento das taxas de controle pela PAC <130/80mmHg e pela MRPA. Estudos com hipertensos idosos têm enfatizado os benefícios de reduções mais intensas da PA na proteção CV.16 Nos obesos, condição de grande impacto sobre os valores de PA,2 foram observados aumentos das taxas de controle da PA de 2019 para 2020, por todos os critérios empregados. Estes dados reforçam a importância da avaliação da PA pelos dois métodos.6Os idosos, em geral com maior dificuldade para o controle da PA,1 e o encontrado em estudo brasileiro com mais de 6500 pacientes,10 o que pode ser explicado pela utilização de ponto de corte menor para a MRPA.18Na amostra total, a distribuição dos fenótipos de hipertensão mudou significativamente de 2019 para 2020, com aumento das taxas de HC e HABNC e redução de HMNC e HNC . Assim, Destacam-se algumas limitações do estudo: 1) a análise de dois cortes transversais de pacientes hipertensos, o que não permite análises da evolução do tratamento; 2) não são conhecidos dados clínicos mais detalhados como estágio da hipertensão arterial, presença de comorbidades e outros fatores de risco CV; 3) não foi possível a análise do uso de medicamentos, informação registrada em menos da metade dos pacientes e de forma incompleta. Por outro lado, destaca-se o número expressivo de pacientes avaliados, com amostras em 2019 e 2020 relativamente homogêneas para a maioria das características demográficas e clínicas consideradas.20 Esses fatores em conjunto mostram importante contribuição da MRPA para aumentar as taxas de controle da PA.Em conclusão, os dados avaliados revelaram aumento da taxa de controle da PA pela PAC <130/80mmHg e pela MRPA em hipertensos tratados. Em 2019, foi iniciado o uso da MRPA de forma mais regular e frequente nesses consultórios, o que pode ter influenciado a prática clínica dos médicos, por uma maior atenção na avaliação da PA fora do consultório e consequente aumento nas taxas de controle da PA de 2019 para 2020. Ressalta-se também que a MRPA facilita o maior engajamento do paciente ao seu tratamento, associa-se à maior adesão e melhor controle da PA.Para informação adicional, por favor, clique aqui 3 Patients with uncontrolled hypertension despite treatment remain at high risk for cardiovascular (CV) events and mortality, comparably to untreated individuals.4Blood pressure (BP) control rates are very low in Brazil and in the world, around 20% only.6 BP control should be monitored by both office BP and out-of-office BP measurements. In this way, it is possible to determine different hypertension phenotypes,6 which is very important to determine the prognosis and individualized therapy.7According to recent recommendations,7 and is associated with lower therapeutic inertia and higher patient engagement and treatment compliance, especially when combined with education and counseling,6 contributing to greater CV protection.8Home monitoring BP (HMBP) is the measurement of BP at home, performed by the patient or another trained person for several days, while awake, using an automated device and a pre-established protocol. HBPM has a low cost, good reproducibility, and good prognostic value. It is well accepted by patientsThe present study aimed to compare BP control rates between office BP and HBPM in two treated hypertensive populations. The individuals were assessed in 2019 and 2020, after the implementation of HBPM into the practice of 274 centers in five different regions of Brazil.This was a multicentric study, of two cross-sectional cohorts, part of the national registry of BP control, evaluated by office BP monitoring and HBPM.5 The tests were analyzed through the TeleMRPA platform (www.telemrpa.com), an instrument that allows remote BP data analysis by telemonitoring.Office BP was considered as the mean of two measurements performed using a validated oscillometric device  on the first day of the HBPM protocol. The same device was used for HBPM. Patients or their caregivers were instructed to take six BP measurements daily.1 Although these values are lower than those adopted by Europeans,6 they showed a higher correlation with an office BP of 140/90mmHg and were associated with lower risk of target organ damage, of CV outcomes and mortality.9 The rates of BP control were analyzed by sex, age group (≥ 60 years and < 60 years), and body mass index (BMI) classification.For analysis of office BP control, two BP cutoffs were considered – < 140/90mmHg and < 130/80mmHg – and for HBPM, the cutoff of < 130/80mmHg was used.6 The phenotypes were classified as: 1) controlled hypertension (CH): normal office BP and HBPM; 2) white coat uncontrolled hypertension (WCUH): abnormal office BP and normal HBPM; 3) masked uncontrolled hypertension (MUH): normal office BP and abnormal HBPM; and 4) uncontrolled hypertension (UH): abnormal office BP and HBPM.The frequency of hypertension phenotypes was determined in 2019 and 2020, considering a BP <140 and 90mmHg and <130 and 80mmHg as normal office BP and HBPM respectively.All patients read and signed the informed consent form. The study was approved by the ethics committee of the Federal University of Goias (CAAE 08208619.8.0000.5078). Data analysis was performed using the SPSS 27.0 (SPSS Inc.), by the Student’s t-test and the chi-square test, rejecting the null hypothesis at the 5% significance level.11 which probably reflects the fact that women care more about their health than men.12 Mean age of the 2020 cohort was significantly higher than the 2019 cohort. Mean systolic BP (SBP) and mean diastolic BP (DBP) were lower by HBPM than office BP , which is in accordance with previous studies.10 In addition, mean DBP measured in the office and by HBPM was lower in 2020 compared with 2019, although the difference between the groups was lower than 1 mmHg , as frequently observed in clinical studies conducted in Brazil,n 1 mmHg . There w3 but similar to those reported in previous Brazilian studies when hypertensive patients were treated by specialists, particularly cardiologists.11Rates of BP control were 57.7% by using an office BP < 140/90mmHg, 28.8% using an office BP < 130/80mmHg and 45.1% pela MRPA < 130/80mmHg . When th13  demonstrated that targeting lower systolic blood pressure than the standard target resulted in higher CV protection, which has been considered by the guidelines.As compared with 2019, in 2020, there was an increase in the control rates for office BP < 130/80 mmHg  and HBPM < 130/80mmHg  . The SPR14It is worth pointing out that the COVID-19 pandemic that started in 2020, could have negatively impacted the BP control rates, and yet, an increase in the control rates was observed instead. A recent Brazilian study with more than 50,000 individuals did not find any influence of the pandemic on BP control rates, determined by office BP or HBPM.12 and in the present study an increase in BP control rates by office BP <130/80mmHg and HBPM was observed in older patients. Studies with older hypertensive patients have emphasized the benefits of greater reductions in BP on CV protection.16 Also, obesity is a condition that has a large impact on BP,2 and we found an increase in BP control rates from 2019 to 2020, by both office BP and HBPM. These data reinforce the importance of evaluating BP by both methods.6Elderly patients usually show greater difficulty in controlling their BP,1 and those reported in a Brazilian study with 6,500 patients,10 which may be explained by the use of a lower cut-off point for HBPM.18In the total sample, the distribution of hypertension significantly changed from 2019 to 2020, with increases in the rates of CH and WCUH, and reductions in MUH and UH . TherefoSome limitations should be noted: 1) the analysis of two cross sectional cohort of hypertensive patients precludes the evaluation of treatment course; 2) more detailed clinical data of the patients are not known, including the stage of hypertension, the presence of comorbidities and other CV risk factors; 3) data on medication use were available (and incomplete) in less than half of patients. On the other hand, one strength of this study was the sample size, with relatively homogeneous cohorts in 2019 and 2020 for most of demographic and clinical features evaluated.20 Altogether, these data demonstrate the important contribution of HBPM in increasing the rates of BP control.In conclusion, the data from this study revealed an increase in BP control rates using both office BP <130/80mmHg and HBPM in treated hypertensive patients. In 2019, HBPM was implemented to be used more frequently, and in a regular manner. This may have influenced the practice of physicians, towards greater attention to the measurement of BP levels out of the office, with a consequent increase in the rates of BP control from 2019 to 2020. In addition, HBPM has improved patient engagement in treatment, and has been associated with higher compliance and better blood pressure control.For additional information, please, click here


To describe data on hearing loss, systemic arterial hypertension and tinnitus of individuals, and to verify the association between self-reported systemic arterial hypertension and tinnitus, as well as to correlate other variables present in the sample: hearing loss and tinnitus, age and tinnitus and age and systemic arterial hypertension.Quantitative, descriptive and inferential, retrospective research with data collection from 473 medical records of adults and elderly people treated between 2008 and 2018. Selected were information on age, gender, result of pure tone audiometry, tinnitus, tinnitus type and frequency, presence of SAH and use of medication to control the disease.No association was found between systemic arterial hypertension and tinnitus or between hearing loss and tinnitus and between age and tinnitus, however, an association was observed between age and systemic arterial hypertension using the Chi - Square test. The most common type of tinnitus was wheezing and most individuals who reported feeling more than one type of tinnitus were hypertensive.The results found and the literature suggest that systemic arterial hypertension may be an additional factor or an aggravating factor of preexisting factors in the generation of tinnitus, but not the primary cause. It can be continuous, intermittent or sporadic and can be felt in one of the ears, in both ears, or “in the head”. Tinnitus is classified as objective when the cause is mechanical in an area attached to the ear or subjective when there are multiple causes or there is no exact cause that triggers it.Tinnitus is defined as an auditory sensation without an external sound stimulus or meaning, which can be experienced as an unpleasant experience, and can impact quality of life. In addition, hearing impairment may be associated with chronic non-communicable diseases such as Systemic Arterial Hypertension (SAH), which is characterized by elevation and maintenance of blood pressure (BP), with systolic pressure equal to or greater than 140 mmHg and diastolic blood pressure equal to or greater than 90 mmHg. It can also be classified as stage 1 with systolic blood pressure of 130 to 139 mm Hg or diastolic BP of 80 to 89 mm Hg and stage 2 with systolic blood pressure of 140 mm Hg or more and diastolic BP of 90 mm Hg or even more. There are several risk factors for tinnitus, and the increase in the prevalence of SAH may be associated with aging, which may be the main determining factor of this increase since many of these factors are modifiable factors such as smoking, alcoholism and physical inactivity.It is a multifactorial clinical condition that affects organs such as the heart, kidneys, blood vessels and the brain, receives blood supply from the anterior inferior cerebellar artery which divides and supports other branches of the ear and may culminate in sudden or progressive hearing loss. In addition, the literature points out that SAH can be one of the causes or aggravating causes of tinnitus, and the alteration of the blood microcirculation of the inner ear is an aggravating factor, as well as the ototoxicity caused by antihypertensive drugs and the perception of noise generated by blood flow due to bony dehiscence of the carotid artery canal,8.Furthermore, the increase in BP can cause hemorrhage in the inner ear, which, like other parts of the body,8.A systematic review that also performed a meta-analysis of the research found on the onset of tinnitus associated with SAH revealed an uncertain relationship. Of the 19 studies found, only eight showed a statistically significant association between tinnitus and SAH.The influence of SAH on the onset or worsening of tinnitus is still unclearTherefore, the present research started from the hypothesis that SAH can act as a primary or an aggravating factor, together with other organic or behavioral factors in the generation of tinnitus. Therefore, the objectives of the present study were to describe data on hearing loss, systemic arterial hypertension and tinnitus of individuals, and to verify the association between SAH and tinnitus, as well as to correlate other variables present in the sample: hearing loss and tinnitus, age and tinnitus and between age and SAH., hearing thresholds within the normal range or bilateral sensorineural hearing loss, bilateral “A” type tympanometric curves, not presenting a history of middle ear alteration, which was verified in the otorhinolaryngologist's progress sheet, not being User of an Individual Sound Amplification Device (HA) at the time of anamnesis or initial evaluation for individuals with hearing loss and the presence of SAH that was self-reported by the individuals so that the blood pressure measurement was not verified.The present research was approved by the Research Ethics Committee of the institution under CAAE 85057518.7.0000.5441, in accordance with the ethical principles of Resolution No. 466/12. Quantitative, descriptive and retrospective inferential with data collection from 473 medical records of adults and elderly people attended between 2008 and 2018, considering the following inclusion criteria: adults aged between 18 and 59 years and elderly people from 60 years of age Since the present is a retrospective study, it was requested not to use the informed consent because most of the information collected was from old medical records, resulting in the impossibility of contacting and inviting patients to sign the term due to various reasons, such as changing contact data not informed, discharge and death.The collection included sociodemographic and audiological data, including tinnitus data such as type and frequency, presence of self-reported SAH and use of medication to control the disease.Data analysis was performed using the Excel program. The treatment of variables was carried out through descriptive statistics using the relative frequency, and was presented through tables and graphs. The associations between the variables collected were analyzed using the chi - square test.A total of 473 medical records were collected from patients who met the inclusion criteria. Of these, 283 (59.8%) were female and 190 (40.2%) were male. The mean age of the individuals was 62.3 ± 17.1 years.Of the total of 473 individuals, 346 (73.2%) had hearing loss. The tinnitus complaint was reported by 255 (53.9%) subjects and the presence of SAH was reported by 208 (44.0%) subjects .Of the individuals who claimed to have SAH, only one (0.5%) reported that they were not using medication to control the disease.Twenty-four (9.4%) subjects reported feeling more than one type of tinnitus, however, the feeling of a single tinnitus prevailed in 231 (90.6%) individuals. Of the total number of subjects who reported more than one type of tinnitus, 16 (66.7%) were hypertensive.Regarding location, 166 (65.1%) reported bilateral tinnitus, 77 (30.2%) reported unilateral tinnitus and 14 (5.5%) reported tinnitus felt “in the head.”Regarding the frequency, the continuous sensation of tinnitus was reported by 126 (49.4%) subjects, frequent by 57 (22.3%) and sporadic by 72 (28.2%) subjects.The type of tinnitus most frequently reported was hissing (32.5%), on the other hand, 21 (7.7%) subjects reported feeling less common types, such as turbine sound, butterfly, rain, crackling, among others, be it this sensation alone or accompanied by other types. It is important to note that, due to some individuals reporting more than one type of tinnitus, the total number of tinnitus types was 274 (100%) .When verifying the association between SAH and tinnitus, no statistically significant difference was found in the relationship between the variables in the population of the present study .When analyzing the relationship between hearing loss and tinnitus, no difference was found for these variables (p>0.05), however, it was observed that of the 187 (100%) individuals diagnosed with hearing loss who reported feeling tinnitus, 103 (54.8%) were classified as having moderate hearing loss, followed by 74 (39.4%) as mild, 11 (5.9%) as severe and none as profound .By dividing the individuals into two groups according to age, it was possible to verify the relationship between age and the occurrence of SAH and tinnitus in the Adult Group up to 59 years , with a There was no relationship between age and the occurrence of tinnitus (p>0.05), however, an association was observed between the variables SAH and age of the individuals (p<0.05). in which one of its objectives was to analyze the prevalence of tinnitus complaints and the possible associations with hearing loss, diabetes mellitus and arterial hypertension in elderly people, and did not find an association between tinnitus and some cardiovascular risk factors, including SAH. This finding may have been influenced by the fact that most individuals in the study used medication to control SAH.In the present study, no association was observed between tinnitus and SAH, and this result corroborates another study. This difference in the findings can be explained by the fact that in the present study, we did not have information regarding the stage of SAH since the presence or absence of hypertension was self-reported, and the SAH measurement was not actually performed. It is therefore suggested that further research be carried out to correlate the type of stage of SAH present in hypertensive patients by verifying the measurement of blood pressure and its influence on the appearance of the tinnitus symptom.However, the result found in the present research is in agreement with another study that aimed to determine the prevalence of tinnitus in hypertensive patients undergoing treatment with antihypertensive drugs whose results were a high prevalence of tinnitus in individuals who had staged hypertension stage 1 or 2, it was found that tinnitus worsens when there is an abrupt increase or decrease in BP, and the control and restoration of BP lead to an improvement in this symptom. Therefore, it can be inferred that SAH may be a cofactor for the generation of tinnitus or an aggravating factor of preexisting alterations, but not its primary cause. (7-15-9)Furthermore, in a systematic review which also found that the complaint of feeling of more than one type of tinnitus is more common in hypertensive individuals. This result was also observed in the present research, because of the total of 24 (100%), the prevalence was 16 (66.7%) hypertensive individuals who reported feeling more than one type of tinnitus.The type of tinnitus reported by the individuals in the present research were the most diverse., Most frequently referred to wheezing, followed by the whistle, and these findings corroborate the study, in two Korean studies,17, and in a study carried out in Pakistan, while in an Italian study the male gender predominated. In another study, no difference was observed between genders. The divergence in the predominance of gender in the various studies may be influenced by the different distribution of the prevalence of organic and behavioral risk factors which occur due to cultural and lifestyle differences in the population of each country. For the present research, the predominance of the female gender may be related to the fact that this gender is one of the risk factors for both SAH and tinnitus-19.Most of the records collected were from female patients. The prevalence of this gender was also observed in a Brazilian study-20. This finding presents a reflection for future research regarding the relationship between the variables age and presence of SAH associated with tinnitus. It is also suggested that further research be carried out to analyze the association of two or more risk factors in the generation of tinnitus.A higher prevalence of SAH among elderly patients was also observed in the present study, a result that corroborates other studiesThere was no association between tinnitus and self-reported SAH, a result that may have been influenced by the use of antihypertensive drugs, as well as the type of stage of SAH. The same occurred in the relationship between hearing loss and tinnitus and the relationship between age and tinnitus.The results found and the analysis of the literature suggest that SAH may be a cofactor or an aggravating factor of preexisting factors in the generation of tinnitus, but not the primary cause. . Pode ser contínuo, intermitente ou esporádico e ser sentido em uma das orelhas, em ambas, ou “na cabeça”. Classifica-se o zumbido como objetivo, quando a causa é mecânica em uma área anexa ao ouvido, ou subjetivo, quando há múltiplas ou não há uma causa exata que o desencadeie. O zumbido é definido como uma sensação auditiva sem um estímulo ou significado sonoro externo, que pode ser vivido como uma experiência desagradável, podendo impactar na qualidade de vida, além disso, o comprometimento auditivo pode estar associado a doenças crônicas não transmissíveis, à exemplo da Hipertensão Arterial Sistêmica (HAS), que é caracterizada pela elevação e sustentação da pressão arterial (PA), com pressão sistólica igual ou maior a 140 mmHg e diastólica igual ou maior a 90 mmHg. A qual também podemos classificá-la em estágio 1, com pressão arterial sistólica de 130 a 139 mm Hg ou PA diastólica de 80 a 89 mm Hg e estágio 2 com pressão sistólica de 140 mm Hg ou mais e PA diastólica de 90 mm Hg ou até mais.Existem diversos fatores de risco para o aparecimento do zumbido, e o aumento da prevalência da HAS pode estar associado ao envelhecimento, podendo este ser o principal fator determinante desse acréscimo uma vez que muitos desses fatores são modificáveis como o tabagismo, alcoolismo e sedentarismo.É uma condição clínica multifatorial que afeta órgãos como coração, rins, vasos sanguíneos e encéfalo, recebe suprimento de sangue provido da artéria cerebelar inferior anterior, que se divide e dá suporte a outros ramos da orelha, podendo culminar em perdas auditivas súbitas ou progressivas. Somado a isso, a literatura aponta que a HAS pode ser uma das causas geradoras ou agravantes do zumbido, sendo a alteração da microcirculação sanguínea da orelha interna um fator agravante, como também, a ototoxicidade causada pelos medicamentos anti-hipertensivos e a percepção de ruído gerado pelo fluxo sanguíneo devido a deiscência óssea do canal da artéria carótida,8.Além disso, o aumento da PA pode causar hemorragia a nível de orelha interna que assim como outras partes do corpo,8. Uma revisão sistemática que também realizou meta-análise das pesquisas encontradas sobre o aparecimento do zumbido associado à HAS revelou uma relação incerta. Das 19 pesquisas encontradas, somente oito apresentaram associação estatisticamente significante entre zumbido e HAS.A influência da HAS no surgimento ou agravamento do zumbido ainda não está claraSendo assim, a presente pesquisa partiu da hipótese de que a HAS pode agir como fator primário ou um agravante, junto a outros fatores orgânicos ou comportamentais, na geração do zumbido. Portanto, os objetivos desse estudo, foram descrever dados da perda auditiva, da hipertensão arterial sistêmica e do zumbido dos indivíduos, e verificar a associação entre HAS e zumbido, bem como correlacionar outras variáveis presentes na amostra: perda auditiva e zumbido, idade e zumbido e entre idade e HAS., limiares auditivos dentro dos padrões de normalidade ou perda auditiva sensorioneural bilateral, curvas timpanométricas do tipo ”A” bilateral, não apresentar histórico alteração de orelha média, que foi verificado na ficha de evolução do otorrinolaringologista, não ser usuário de Aparelho de Amplificação Sonora Individual (AASI) no momento da anamnese ou avaliação inicial para os indivíduos com perda auditiva e a presença da HAS que foi autorreferida pelos indivíduos, de modo que não foi verificado a medida de pressão arterial.Trata-se de pesquisa aprovada pelo Comitê de Ética em Pesquisa da instituição, sob o CAAE 85057518.7.0000.5441, de acordo com os princípios éticos da Resolução n° 466/12. Quantitativa, descritiva e inferencial retrospectiva com coleta de dados de 473 prontuários de adultos e idosos atendidos entre os anos 2008 e 2018, contemplando os seguintes critérios de inclusão: adultos na faixa etária de 18 a 59 anos e idosos a partir de 60 anosPor se tratar de um estudo retrospectivo, foi solicitado a não utilização do TCLE devido grande parte das informações coletadas serem de prontuários antigos, acarretando na impossibilidade de contatar e convidar os pacientes para assinatura do termo devido diversos motivos, como alteração de dados de contato não informada, recebimento de alta e óbito.A coleta contemplou dados sociodemográficos, audiológicos, incluindo dados do zumbido como tipo e frequência, presença de HAS autorreferida e uso de medicamento para controle da doença.A análise dos dados foi realizada com o auxílio do programa Excel. O tratamento das variáveis foi realizado através de estatística descritiva, com uso da frequência relativa, e sua apresentação por meio de tabelas e gráficos. As associações entre as variáveis coletadas foram analisadas através do teste Qui-quadrado.Foram coletados 473 prontuários de pacientes que atenderam aos critérios de inclusão. Destes, 283  do gênero feminino e 190  do gênero masculino. A média de idade dos indivíduos foi de 62,3 ± 17,1 anos.Do total de 473 indivíduos, 346  apresentaram perda auditiva. A queixa de zumbido foi referida por 255  sujeitos e a presença de HAS foi referida por 208  indivíduos .Dos indivíduos que afirmaram ter HAS, somente um  referiu que não estava utilizando medicamento para controlar a doença.Vinte e quatro  sujeitos referiram sensação de mais de um tipo de zumbido, no entanto, prevaleceu a sensação de um único zumbido em 231  indivíduos. Do total de sujeitos que referiram mais de um tipo de zumbido, 16  eram hipertensos.Quanto à localização, foram observados 166  relatos de zumbido bilateral, 77  de zumbido unilateral e 14  relatos de zumbido sentido “na cabeça”.Quanto à frequência, a sensação contínua do zumbido foi referida por 126  sujeitos, frequente por 57  e esporádico por 72  indivíduos.O tipo de zumbido mais frequentemente relatado foi o chiado , por outro lado, 21  sujeitos referiram sentir tipos menos comuns, como som de turbina, borboleta, chuva, estalo, entre outros, seja esta sensação a única ou acompanhada de outros tipos. É importante ressaltar que, devido a alguns indivíduos terem relatado mais de um tipo de zumbido, o n total do tipo de zumbido foi de 274 (100%) .Ao verificar a associação entre HAS e zumbido, não foi encontrada diferença estatisticamente significativa da relação entre as variáveis na população da presente pesquisa .Ao realizar a análise da relação entre perda auditiva e zumbido, também não foi encontrada diferença para estas variáveis , no entanto, foi observado que dos 187 (100%) indivíduos diagnosticados com perda auditiva que referiram sentir zumbido, 103  foram classificados com perda auditiva de grau moderado, seguido de 74  com grau leve, 11  com grau severo e nenhum com grau profundo .Ao dividir os indivíduos em dois grupos de acordo com a faixa etária, foi possível verificar a relação entre a idade e a ocorrência da HAS e do zumbido no Grupo Adulto até 59 anos , com o tNão foi observada relação entre a idade e a ocorrência de zumbido , no entanto, foi observada associação entre as variáveis HAS e idade dos indivíduos . em que um dos seus objetivos foi analisar a prevalência da queixa de zumbido e as possíveis associações com perda auditiva, diabetes mellitus e hipertensão arterial em pessoas idosas, que não verificou associação entre zumbido e alguns fatores de risco cardiovasculares, inclusive a HAS. Esse achado, pode ter sido influenciado pelo fato da maioria dos indivíduos desse estudo, utilizarem medicamento para controle da HAS.No presente estudo, não foi observada associação entre zumbido e HAS, e esse resultado corrobora com um estudo. Essa diferença dos achados, pode ser explicada diante do fato de na presente pesquisa, não termos a informação em relação ao estágio da HAS, visto que a presença ou não da hipertensão foi autorreferida, não sendo realizado a medida da HAS de fato. É sugestível então, a realização de mais pesquisas para correlacionar o tipo de estágio da HAS presente nos pacientes hipertensos, através da verificação da medida da pressão arterial e a sua influência no aparecimento do sintoma zumbido.Entretanto, o resultado encontrando na presente pesquisa, vai de encontro a outro estudo que teve como objetivo determinar a prevalência do zumbido em pacientes hipertensos em tratamento com anti-hipertensivos, cujo os resultados foram de alta prevalência de zumbido nos indivíduos que tinham hipertensão em estágio 1 ou estágio 2, foi verificado que o zumbido se agrava quando ocorre o aumento ou diminuição abrupta da PA, bem como o controle e restabelecimento da PA, levam a uma melhora desse sintoma. Sendo assim, pode-se inferir que a HAS pode ser um cofator para a geração do zumbido, ou um agravante de alterações preexistentes, mas não sua causa primária (7-15- 9).Além disso, em uma revisão sistemática que também verificou que a queixa de sensação de mais de um tipo de zumbido é mais comum em indivíduos hipertensos. Este resultado também foi observado nesta pesquisa, pois do total de 24 (100%), a prevalência foi de 16  indivíduos hipertensos que referiram sentir mais de um tipo de zumbido.O tipo de zumbido referido pelos indivíduos nessa pesquisa, foram os mais diversos, sendo o mais frequentemente referido o chiado, seguido do apito, e esses achados corroboram com o estudo, em dois estudos coreanos,17, e em um estudo realizado no Paquistão,enquanto que em uma pesquisa italiana apresentou predominância do gênero masculino em sua população. Em outro estudo, não foi observado diferença entre os gêneros. A divergência do predomínio de gênero nas diversas pesquisas pode ser influenciada pela diferente distribuição da prevalência dos fatores de risco orgânicos e comportamentais, que ocorrem devido às diferenças culturais e de estilo de vida da população de cada país. Para a presente pesquisa, a predominância do gênero feminino pode estar relacionada ao fato de este gênero ser um dos fatores de risco tanto para a HAS quanto para o zumbido-19.A maioria dos prontuários coletados foram de pacientes do gênero feminino. A prevalência deste gênero também foi observada em uma pesquisa brasileira-20. E esse achado traz uma reflexão para pesquisas futuras no tocante a relação entre as variáveis idade e presença de HAS associado ao zumbido. Sugere-se também, a realização de novas pesquisas que analisem a associação de dois ou mais fatores de risco na geração do zumbido.Também foi observado na presente pesquisa, uma maior prevalência da HAS entre os pacientes idosos, resultado esse que corrobora com outros estudosNão foi observada associação entre zumbido e HAS autorreferida, resultado esse que pode ter sido influenciado pelo uso de medicamentos anti-hipertensivos, como também, o tipo de estágio da HAS. O mesmo ocorreu na relação entre perda auditiva e zumbido e a relação entre a idade e o zumbido.Os resultados encontrados e a análise da literatura sugerem que a HAS pode ser um cofator ou um agravante de fatores preexistentes na geração do zumbido, porém não a causa primária.


In the published article, there was an error in the Funding statement. Coordination for the Improvement of Higher Education Personnel (CAPES), and Conselho Nacional de Desenvolvimento Científico e Tecnológico-CNPq and Ministério da Saúde-MS (308771/2020-6) should be removed. The correct Funding statement appears below.This study was funded by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico—CNPq/Ministério da Saúde do Brasil (442990/2019-7), Fundação de Amparo à Pesquisa do Estado de Minas Gerais—FAPEMIG (APQ-00341-21), and Pró-Reitoria de Pesquisa da Universidade Federal de Minas Gerais.The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.The original article has been updated.All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Journal of the Canadian Health Libraries Association (JCHLA) will be available through PubMed Central (PMC) in the coming months. A big thank you to the current and previous editorial members who contributed to the PMC application process and to the board of the Canadian Health Libraries Association (CHLA) for their support.I hope everyone has been enjoying the summer months and that this issue finds you on a sunny day – or with one on the horizon! I am excited to share with you that the I’d like to say a warm welcome to Meredith Fischer (Wilfrid Laurier University) who joined us in May as our new Copyeditor, and a big thank you to Amanda Caputo  who completed her term in April. As this is my third issue as Editor-in-Chief, it is also my final. I have truly enjoyed working with all the members of both the editorial team and CHLA board over the past three years, participating in the development and launch of JCHLA’s data sharing policy and taking steps forward with the team to address equity, diversity and inclusion through the journal’s practices and publication process. As of September 1, 2022 Colleen Pawliuk  will be Editor-in-Chief, Megan Kennedy (University of Alberta) Senior Editor and our incoming Junior Editor is Jessica McEwan (Ottawa University). Welcome Jessica!Responding to Rapid Change in Libraries: A User Experience Approach. We also have a research article from Miller and Janke and the winning 2021 student paper prize by Graham and Moleirinho. Watch for the 2022 student paper prize by Vinson Li in a future issue of JCHLA! You can also find the CHLA 2022 conference abstracts in this issue including interactive workshops, contributed papers, lightning talks and poster presentations. Thank you to all our authors and peer reviewers for your contributions!We have a great lineup for you in this issue of JCHLA, beginning with a review of the book Alanna CampbellJCHLA/JABSC Editor-in-Chiefeditor@chla-absc.caEmail: J'espère que tout le monde a profité des mois d'été et que vous lisez ce numéro par une journée ensoleillée - ou une qui se profile à l’horizon ! Je suis heureuse de vous annoncer que le Journal de l'Association des bibliothèques de la santé du Canada (JABSC) sera disponible sur PubMed Central (PMC) au cours des prochains mois. Un grand merci aux membres de la rédaction, qui ont contribué au processus de demande auprès de PMC ainsi qu’ au conseil d'administration de l'Association des bibliothèques de la santé du Canada (ABSC) pour leur soutien.J'aimerais souhaiter la bienvenue à Meredith Fischer (Université Wilfrid Laurier) qui nous a rejoint en mai, en tant que nouvelle réviseure, et remercier Amanda Caputo  qui a terminé son mandat en avril. Pour ma part, ce troisième numéro en tant qu’ éditrice en chef, sera aussi mon dernier. Au cours des trois années qui viennent de s’écouler, j'ai vraiment apprécié : travailler avec tous les membres de l'équipe de rédaction et le conseil d'administration de l'ABSC, participer à l'élaboration et au lancement de la politique de partage des données de l'ABSC et prendre des mesures avec l'équipe, pour aborder l'équité, la diversité et l'inclusion dans les pratiques et le processus de publication de la revue. À compter du 1er septembre 2022, Colleen Pawliuk  sera éditrice en chef, Megan Kennedy (Université de l'Alberta) éditrice principale et Jessica McEwan (Université d'Ottawa), notre nouvelle éditrice débutante. Bienvenue à Jessica!Responding to Rapid Change in Libraries : A User Experience Approach. Nous avons également un article de recherche de Miller et Janke et le prix 2021 pour un article étudiant par Graham et Moleirinho. Surveillez l'article de Vinson Li, lauréat du prix 2022, dans un prochain numéro du JABSC ! Vous trouverez également dans ce numéro les résumés du congrès 2022 de l'ABSC, notamment les ateliers interactifs, les communications, les présentations éclairs et les affiches. Merci à tous nos auteur.es et évaluateur.rices pour leurs contributions !Ce numéro du JABSC vous réserve plusieurs articles de qualité, à commencer par une critique du livre Alanna CampbellRédactrice en chef, JABSC / JCHLAeditor@chla-absc.caCourriel:


In the published article, the author’s names were incorrectly written as “Celine Audiger, Gaelle Abihsera, Jerome Nicolet.” The correct spelling’s are “Céline Audiger, Gaëlle Abihsera, Jérôme Nicolet.”1, 2, 3. Instead of “1CRCDC-IDF, Paris, France, 2INSERM U1136 Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris, France, 3UMR7533 Laboratoire Dynamiques Sociales et Recomposition des Espaces (LADYSS), Nanterre, France.” It should be “1Le Centre Régional de Coordination des Dépistages des Cancers-CRCDC, Paris, France, 2Sorbonne Université, INSERM, Institut Pierre Louis d’épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France, 3Université Paris Nanterre, UMR CNRS 7533 LADYSS, Nanterre, France.”In the published article, there was an error in affiliations 1, they should also have affiliation 2.In the published article, there was an error regarding the affiliation for Céline Audiger. As well as having affiliation The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


Welcome to the December issue of JCHLA/JABSC! As incoming Editor-in-Chief I want to first thank Alanna Campbell, former Editor-in-Chief, who led the successful effort to have JCHLA/JABSC indexed in PubMed Central. I also want to welcome the new members to the Editorial Board: Jessica McEwan, Junior Editor, and Meredith Fischer, Copyeditor.Driving diversity, equity, and inclusionto shape the future of publication ethics” presented by the Committee on Publication Ethics (COPE). The focus of our meeting was on how to bring what we learned from the speakers into our practice in each of our roles and to JCHLA/JABSC as a whole. The discussion sparked several ideas for how we can take action to make JCHLA/JABSC more inclusive for our authors, readers, reviewers and Editorial Board members. I hope to share more detail of this work in the coming months. I also want to continue the call to encourage our authors to consider submitting their work related to EDI to JCHLA/JABSC.In our continued work to educate ourselves on topics related to Equity, Diversity, and Inclusion (EDI), the Editorial Board met in November to discuss the webinar “Academic libraries and collaborative research services and Communities of practice in the academic library: strategies for implementation.This issue we have the JCHLA/JABSC Student Paper Prize winning article by Vinson Li, which uses bibliometric methods to map the field of health science librarianship research. Also, in this issue are two books reviews, We hope you enjoy the December issue!Colleen PawliukJCHLA/JABSC Editor-in-Chiefeditor@chla-absc.caEmail: Bienvenue au numéro de décembre de JABSC / JCHLA ! En tant que nouvelle rédactrice en chef, je tiens tout d’abord à remercier Alanna Campbell, l’ancienne rédactrice en chef, qui a mené à bien les efforts visant à indexer JABSC / JCHLA dans PubMed Central. Je tiens également à souhaiter la bienvenue aux nouvelles membres du comité de rédaction : Jessica McEwan, rédactrice en chef adjointe, et Meredith Fischer, correctrice.Driving diversity, equity, and inclusion to shape the future of publication ethics» présenté par le Committee on Publication Ethics (COPE). Notre réunion s’est concentrée sur la façon de mettre en pratique ce que nous avons appris des conférenciers et conférencières dans chacun de nos rôles et au sein du JABSC / JCHLA dans son ensemble. La discussion a suscité plusieurs idées sur la façon dont nous pouvons agir pour rendre JABSC/JCHLA plus inclusif pour nos auteurs et autrices, notre lectorat, nos réviseurs et réviseures et les membres du comité de rédaction. J’espère partager plus de détails sur ce travail dans les mois à venir. Je souhaite également continuer à encourager nos auteurs et autrices à envisager de soumettre leurs travaux relatifs à l’EDI au JABSC / JCHLA.Dans le cadre de notre travail continu d’éducation sur les sujets liés à l’équité, la diversité et l’inclusion (EDI), le comité de rédaction s’est réuni en novembre pour discuter du webinaire «Academic libraries and collaborative research services et Communities of practice in the academic library : strategies for implementation.Dans ce numéro, nous présentons l’article de Vinson Li, qui a remporté le prix de l’article étudiant du JABSC / JCHLA, et qui utilise des méthodes bibliométriques pour cartographier le domaine de la recherche en bibliothéconomie des sciences de la santé. Vous trouverez également dans ce numéro deux comptes rendus de livres, Nous espérons que vous apprécierez ce numéro de décembre !Colleen PawliukRédactrice en chef, JABSC / JCHLAeditor@chla-absc.caCourriel: